ProHance - 0270-1111-02 - (gadoteridol)

Alphabetical Index


Drug Information of ProHance

Product NDC: 0270-1111
Proprietary Name: ProHance
Non Proprietary Name: gadoteridol
Active Ingredient(s): 279.3    mg/mL & nbsp;   gadoteridol
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of ProHance

Product NDC: 0270-1111
Labeler Name: Bracco Diagnostics Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021489
Marketing Category: NDA
Start Marketing Date: 20031009

Package Information of ProHance

Package NDC: 0270-1111-02
Package Description: 5 VIAL, SINGLE-DOSE in 1 BOX (0270-1111-02) > 15 mL in 1 VIAL, SINGLE-DOSE

NDC Information of ProHance

NDC Code 0270-1111-02
Proprietary Name ProHance
Package Description 5 VIAL, SINGLE-DOSE in 1 BOX (0270-1111-02) > 15 mL in 1 VIAL, SINGLE-DOSE
Product NDC 0270-1111
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name gadoteridol
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20031009
Marketing Category Name NDA
Labeler Name Bracco Diagnostics Inc
Substance Name GADOTERIDOL
Strength Number 279.3
Strength Unit mg/mL
Pharmaceutical Classes Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC]

Complete Information of ProHance


General Information